John A. Orwin Joins Array BioPharma Board Of... ( BOULDER Colo. Nov. 7 2012 /- Arr...)

John A. Orwin Joins Array BioPharma Board Of Directors

Date:11/7/2012

BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that as part of its continued evolution toward late-stage development and commercialization, John A. Orwin, chief executive officer of Affymax, Inc., joined the Company's board of directors, effective November 6, 2012.

(Photo: http://photos.prnewswire.com/prnh/20121107/LA07637)

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Mr. Orwin has served as the chief executive officer of Affymax since 2011, after joining the company in 2010 as its chief operating officer. Previously, he held leadership roles in marketing, sales, and operations for major pharmaceutical companies including Genentech, Johnson & Johnson, Alza Pharmaceuticals, Rhone-Poulenc Rorer, and Schering-Plough Corporation.

Mr. Orwin brings a track record of substantial accomplishment in the pharmaceutical industry to Array's board of directors. Over his career, Mr. Orwin has built successful businesses and commercialized a range of blockbuster products. Most recently, he led the approval and launch of Omontys®, a hematology product for the treatment of anemia in chronic kidney disease. Prior to joining Affymax, he led Genentech's BioOncology business unit and grew a portfolio of cancer-fighting products including Avastin®, Rituxan®, Herceptin® and Tarceva® to over $7 billion in U.S. sales. Earlier in his career, he was responsible for the successful launch of Taxotere®, exceeding budget and forecast expectations.

Ron Squarer, chief executive officer of Array, noted, "At a time when Array is moving towards commercialization of our pipeline, John has the perfect background to compleme
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Robert Farrell Joins Bionovos Board of Directors
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
5. First Choice Rehabilitation Specialists Joins Select Medical
6. Excel Life Sciences Joins DATATRAKs Connect Partner Program
7. Marina Biotech, Inc. Joins OTCQX
8. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
9. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
10. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
11. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team

Post Your Comments:

(Date:5/21/2013)... The congress of the ERA-EDTA (European Renal Association ... congress in Europe on nephrology ... Istanbul to share their knowledge ... have been presented: / (1) Gupta, A ... REDUCES ESA USE" By SFP-iron administration, the ...

(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...

(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...

(Date:5/21/2013)... 2013 Many have long discussed the ... acne. Recently physicians from Clinical Psychiatry.com readdressed ... the skin, and suggested using hypnotherapy and ... produced from stress that cause acne. , Doctors in ... acne brings about, stress causes changes in the skin ...

Breaking Biology Technology:ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2 ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5 Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2

[0] ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials [0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC [0] The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research [0] Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions

... Productivity. , ... Grand Forks, ND (Vocus) December 10, ... individual management practices and fields will become increasingly important to growers, ... Research and Development, will tell agricultural leaders today at the ...

... Dosing Regimen , , ... long-acting therapy (LAT) demonstrated statistically significant symptom control compared ... study presented today (1). Statistical significance was evidenced ... equivalent [eq.a]), when given every 4 weeks with a ...

... Journal Blood for the American Society of Hematology Annual Meeting ... 10 Alfacell Corporation (Nasdaq: ACEL ) today ... in Blood (2008 112: Abstract 4205 & 2008 ... show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute ...

Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells

(Date:5/20/2013)... articles posted online ahead of print 9 ... of geoscience subdisciplines, including minerals exploration, archaeology, planetary ... include Siberia; the Sumatran subduction margin; the Monte ... and the Southeastern U.S. Atlantic Margin. Brief highlights ... tectonics;, 2. The clear fingerprint of ice ages ...

(Date:5/19/2013)... engineered a strain of photosynthetic cyanobacteria to grow without ... today at the 113th General Meeting of the American ... synthetic biology approaches to probe and rewire photoautotrophic (exclusively ... cyanobacterial metabolism for the ability to grow without light ... study. He is part of Shota Atsumi,s lab ...

(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...

[0] New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More [0] Engineered microbes grow in the dark [0] Research examines new methods for managing digestive health

... species previously unknown to science have been discovered on ... environment surrounding hydrothermal vents. The discoveries, made by ... Southampton and British Antarctic Survey, include new species of ... octopus. For the first time, researchers have used ...

... 2011 By manipulating the way bacteria "talk" to ... an unprecedented degree of control over the formation and ... health and industrial applications, particularly to bioreactor technology. ... K. Wood and Associate Professor Arul Jayaraman of the ...

... disguised herself as a man to work as ... French circumnavigation of the globe. The expedition consisted of ... Bougainville and was expected to take three years. A ... vessels; prejudice and custom prevented their participation in science. ...

Cached Biology News:'Lost world' discovered around Antarctic vents 2 Manipulating way bacteria 'talk' could have practical applications, Texas A&M profs say 2 Manipulating way bacteria 'talk' could have practical applications, Texas A&M profs say 3 Jeanne Baret, botanist and first female circumnavigator, finally commemorated in name of new species 2

'Lost world' discovered around Antarctic vents Manipulating way bacteria 'talk' could have practical applications, Texas A&M profs say Jeanne Baret, botanist and first female circumnavigator, finally commemorated in name of new species

... MagCellect Ferrofluid products perform optimally ... R&D Systems MagCellect Magnet. To ... neodymium iron boron permanent magnet ... 75 mm test tubes or ...

... 0 (or Cap 0-like) RNA into Cap ... been shown to increase in vivo translation ... is seen in Cap 0 structures created ... well as those Cap 0 structures created ...

Request Info...

Form: Ready to use Applications: Western Blot, ELISA...

Biology Products:

MagCellect Magnet from R&D Systems ScriptCap 2'-O-Methyltransferase from EPICENTRE Biotechnologies Streptavidin, Alkaline Phosphatase conjugated/tagged from AbD Serotec TMB ONE DILUENT from AbD Serotec